Indianapolis, IN, United States of America

Uko Effiong Udodong

This inventor holds 4 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2000-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uko Effiong Udodong. Retrieved from https://idiyas.com/inventor/uko-effiong-udodong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Uko Effiong Udodong: Innovator in Pharmaceutical Chemistry

Introduction

Uko Effiong Udodong is an esteemed inventor based in Indianapolis, Indiana, with a remarkable contribution to the field of pharmaceutical chemistry. With four patents to his name, he has established himself as an innovator, specifically in the development of methods for producing novel chemical compounds that have significant implications in medicine.

Latest Patents

Among his latest patents, Uko has developed methods for producing chiral chromones, chromanes, and amino-substituted chromanes. This invention discloses process steps for creating chromane compositions enriched in specific enantiomers, which are vital for producing platelet aggregation inhibitors. These chroman-2-yl carboxylic acid compounds serve as key intermediates in developing potent medications aimed at treating various health conditions. Additionally, he has patented processes related to pyrrolo[3,2-b]pyridine, which involve intermediates essential for synthesizing 5-amino-3-(1-methylpiperidin-4-yl)pyrrolo-[3,2-b]pyridine. Both of these inventions showcase Uko's innovative approaches to complex chemical processes.

Career Highlights

Uko Effiong Udodong works at Eli Lilly and Company, a global leader in the pharmaceutical sector. His role at the company has positioned him at the forefront of research and development, allowing him to contribute significantly to advancements in drug manufacturing and chemistry. His expertise has not only led to the successful patenting of his work but has also positioned him as a valuable asset to the innovative culture at Eli Lilly.

Collaborations

Throughout his career, Uko has collaborated with notable coworkers, including Daniel Edward Verral, II, and John Leo Grutsch, Jr. These partnerships highlight the collaborative spirit within the research community at Eli Lilly, where teamwork often results in groundbreaking innovations in pharmaceuticals.

Conclusion

Uko Effiong Udodong exemplifies the spirit of innovation in the field of pharmaceutical chemistry. His contributions, evidenced by multiple patents, demonstrate his commitment to advancing drug development processes and enhancing the efficacy of medications. As the pharmaceutical industry continues to evolve, inventors like Uko will play a pivotal role in shaping the future of health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…